Imation signs OEM deal with Imaging Diagnostics:
This article was originally published in Clinica
Imaging Diagnostics Systems and Imation have agreed an OEM purchase agreement so that IDS can market its laser mammography device with Imation's dry film technology. Imation is developing a femto-second pulsed titanium sapphire laser with computer assistance, which it is claimed improves early detection, reduces the need for biopsy and does not require breast compression.
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.